Events

ARTEMIS will be present at the following events and will be pleased to discuss any project requirement you may have.

News

Germantown and Cologne, November 27, 2007
Taconic aquires 80% stake in ARTEMIS
more...

Germantown und Köln, 27. November 2007
Taconic erwirbt 80%ige Mehrheitsbeteiligung an ARTEMIS
more...

Cologne, May 29, 2007
ARTEMIS and NGFN sign cooperation.
more...

Hudson and Cologne, May 2, 2007
ARTEMIS and Taconic Acquire Chemical Genetics Technology From CGI Pharmaceuticals, Inc.
more...

Cologne, 22. March 2007
ARTEMIS Announces Publication on a Novel RNAi-based Approach for Inducible and Reversible Gene Knockdown in Transgenic Mice
more...

Cologne, 29. January 2007
Artemis Pharmaceuticals, CLEA Japan, Inc. and In-Vivo Science, Inc. Form Strategic Alliance for Generation and Marketing of Genetically Engineered Mouse Models
more...

Köln, 29. Januar 2007
Strategische Allianz von Artemis Pharmaceuticals, CLEA Japan und In-Vivo Science, Inc. zur Generierung und Vermarktung genetisch modifizierter Mäuse.
more...

Cologne, 4. January 2007
Artemis scientist publish proprietary technique on "Automated sorting of genetically engineered embryonic stem cells for generation of mouse models" in Nature Methods.
Further information on request.

Köln, 4. Januar 2007
ARTEMIS Wissenschaftler publizieren ihre proprietäre Methode zur "Automatisierten Sortierung von genetisch modifzierten Stammzellen für die Generierung von Maus Modellen" in Nature Methods.
Weitere Informationen auf Anfrage.

Cologne, 20. November 2006
ARTEMIS Signs Agreement with Merck & Co., Inc. for Generation of Genetically Engineered In-Vivo RNAi Mouse Models
more...

Köln, 20. November 2006
ARTEMIS Pharmaceuticals unterzeichnet Forschungsvereinbarung mit Merck & Co., Inc. auf dem Gebiet der RNA-Interferenz
more...

Cologne, 31. October 2006
ARTEMIS and Haptogen Enter Scientific Collaboration: Joint development of novel in vivo models for preclinical evaluation of therapeutic antibodies
more...

Köln, 31. Oktober 2006
ARTEMIS and Haptogen vereinbaren Forschungskooperation: Gemeinsame Entwicklung neuartiger in vivo Modelle zur präklinischen Testung therapeutischer Antikörper
more...

Cologne, 26. October 2006
ITI Life Sciences licences innovative drug safety testing technology to CXR Biosciences and ARTEMIS Pharmaceuticals
more...

Köln, 26. Oktober 2006
Kommerzielle Nutzungssrechte an ARTEMIS Pharmaceuticals und CXR Biosciences ITI Life Sciences erteilt Lizenz zum Einsatz neuartiger transgener Mausmodelle in der Arzneimittelforschung
more...

Cologne, 28. February 2006
ARTEMIS Pharmaceuticals Announces Collaboration Agreement with Bristol-Myers Squibb
more...

Köln, 28. Februar 2006
ARTEMIS Pharmaceuticals und Bristol-Myers Squibb unterzeichnen Kooperationsvertrag
more...